XLO - Xilio Therapeutics GAAP EPS of -$0.62 May, 14 2024 09:22 AM Xilio Therapeutics Inc. 2024-05-14 09:22:39 ET More on Xilio Therapeutics Xilio Therapeutics reports Q4 results Xilio stock jumps on Gilead Sciences license deal Seeking Alpha’s Quant Rating on Xilio Therapeutics Historical earnings data for Xilio Therapeutics Financial information for Xilio Therapeutics For further details see: Xilio Therapeutics GAAP EPS of -$0.62